<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 312 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page311.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=312">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 312 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 312</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=312"><img src="../thumb/312.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>Anti-Microbials - 18.12                                                        2020-04 / 275
       Dosage: Consult.prod.info.of each therapeut. compon. of regim.bef.  Dosage: Adults: 1 tab.swall.whole once dly.on empty stomach.   Integrase inhibit.resist.: 50 mg 2xdly.
       init.treatm., init.ther.by physic. exper.in HIV infect.managem. Adults:   Bedt.dos.may improv.CNS sympt. tolerabil.  Contraindications: Concom.dofelitide/ pilsicainide/ metformin,
       1 tab. once dly. Rifampicin decr.bld.lev.of dolutegravir & supplement.  Regul.dos.sched.advis. If dos.miss., take miss.dos. immed.unless it   mod./sev.hepat.impairm.
       dos.of dolutegravir poss.reqd.  is 12 hrs unt.next day’s dos. In this case skip miss.dos.& take next   Side effects: Freq: Fatig., headache, dizzin., abnorm.dreams, hep-
       Contraindications: Mod.to sev.liv funct. impairm., ren.funct.im-  dos.at usual time.  atit., incr.AST/ALT/CPK/ bilirub., insomn., depress., naus., diarrh.,
       pairm., pregn.& lactat., women of child-bear.age not using highly ef-  Contraindications: Chron.HBV infect., mod-sev. ren.impairm., safe-  vomit., flatul., upper abdom.pain, rash, prurit. Less freq: Abdom.
       fect. contracept., concom.adefovir dipivoxil/dofetilide/ pilsicainide/  ty & effic.in pregn.not est., lactat., concur.terfenadine/astemizole/  pain/discomf., hypersens., immune reconstit. syndr, suicid.ideat./
       didanosine/metformin, pts. &lt;18 yrs.  cisapride/ midazolam/ triazolam/ergot derivat./voriconazole/ bepri-  attempt, elev.ser. lipid/ gluc.lev., osteonecros.esp.in advanc.HIV &/
       Side effects: Freq: Hyperlactataem., headache, insomn., cough,   dil/ pimozide, safety & effic.in pts.less than 18 yrs.not est., sev.hepat.  longt.expos.to combin.ARV ther., auto-immune disords.
       nas.sympts, upper abdom.pain/ cramps, N&V, diarrh., trans.liv.en-  impairm., safety & effic. not est.in HBV & HIV co-infects., cytidine   Warnings and special precautions: Safety in pregn.& lactat.not
       zymes incr., alopec., rash, arthralg., musc.disords./pain, fatig., ma-  analog. such as lamivudine, adefovir dipivoxil, concom. amprenavir/   est., cross. placent. barrier in animals, excret.in breast milk, limit.
       laise, fev., dizzin., anorex., distent., dyspeps., flatul., ren.insuffic./  ritonavir, atazanavir/ritonavir, lopinavir/ ritonavir, saquinavir/ritonavir   data in elderly ≥ 65 yrs., do not use with etravine without concom.
       fail., proxim.ren.tubulopathy, proteinur., ac.tubul.necros., nephroen.  not recomm., concom.didanosine not recomm.  atazanavir/ritonavir, darunavir/ ritonavir or lopinavir/ritonavir com-
       diab.insipid., asthen., abnorm.dreams, vertigo, prurit. Less freq:   Side effects: Lactic.acidos.& sev.hepatomegaly with steatos.incl.  binat., avoid concom. oxcarbazepine/ phenytoin/phenobarb./ car-
       Neutropen., anaem., thrombocytopen., pure red cell aplas., im-  fatal.esp.in women, sev.ac. exacerbat.of hepatit. B aft.discontinuat.  bamazepine/St.John’s Wort, admin.2 hrs.bef./ 6 hrs. aft.antacids
       mune reconstit.inflamm.syndr., angioed., lact.acidos., lipodystrophy,   of emtricitabine/ tenofovir, ser.CNS & psych.sympts., ren.impairm.  contain.polyval.cations, discont. ther./ other suspect.agents immed.if
       metabol. abnorm. incl.hypertriglyceridaem./ hypercholesterolaem./   incl.ac.ren.fail., neutropen., anaem., hypertriglyceridaem., hypergly-  any signs/ sympt. of hypersens.devel., monit.clinic.status incl. LFT &
       insulin resist/ hyperglycaem/ hyperlactatem./hypokalaem., abnorm.   caem., headache, asthen., depress. disords., dizzin., sleep disturbs.,   init.appropr.ther., CV risk assessm.with lipodystrophy evid., immune
       behav., periph.neuropathy, paraesthes., late onsert neurologic.dis-  neurit., paraesthes., periph.neuropathy, incr.cough, rhinit., GI disturbs.  reconstit.syndr., alert physic.to joint aches/pain/stiffn./movem.dif-
       ords.in childr.expos.in utero, convuls., pancreatit., incr.ser.amylase,   incl.gastr-oesophag.reflux/ malabsorpt., rais.liv.enzym., hyperbiliru-  fic., opportunist. infects.& other complicat.of HIV infect. may contin.,
       hepatit., rhabdomyolys., decr.bone mineral dens., osteopen, fract.,   binaem., skin reacts. incl.hyperpigment.on palms &/soles & rash./  transmiss.risk through sex. contact/contam.bld.not reduc., hepat.im-
       hyperton., myalg., myosit., osteonecros., breast enlargem., allerg.  erythem.multiforme/nail disords./Stev.-John. syndr., arthralg., myalg.,   pairm., monit. liv.funct.in hepatit.B &/C co-infect., init./ maint.effect.
       react. incl. angioed., hepatomegaly, steatos., bone pain, osteoma-  myopathy, haematur., allerg. reacts., hypophosphataem., chest pain,   hepatit.B ther.when start.dolutegravir in hepatit.B co-infect., eval.
       lac., musc.weakn., myopathy, hyperton., nephrit., anx., depress.,   pneum., dyspn., hepatotoxic., hepatit., nephrit., nephrogen. diabet.  any inflamm.sympt.& init. ther.if necess.
       paranoia, suic.ideat., gastrit., Stev.John.syndr., tox.epiderm.necrolys.   insipid., ren.proxim. tubul.eff. incl.Fanconi syndr.& ac.tubul.necros.,   Interactions: Decr.plasma conc.with etravine, efavirenz, rifampicin,
       Freq. unknown: Dyspn., pneum., neural tube defects, late onset   fev., sweat., weight chang., pancreatit., palpitat., hypoaesthes., ab-  tipranavir/ritonavir, fosamprenavir/ ritonavir, potent.decr.conc.with
       neurologic.disords.incl.seiz.  norm. dreams/co-ordinat., atax., convuls., agitat., amnes., tremor,   nevirapine, decr.conc.with oxcarbazepine/ phenytoin/ phenobarb./
       Warnings and special precautions: Not indicat. for treatm of   anx., apathy, confus., emot. labilit., imp.co-ordinat., impot., libido   carbamazepine/St.John’s Wort, incr.metformin conc., incr.plasma
       chron.HBV infect., safety & effic. not est.in HBV & HIV co-infects.,   chang., neuralg., speech disord., vertigo, abnorm. vis., tinnit., taste   conc.with atazanavir/ ritonavir, incr.AUC & C max with atazanavir, po-
       monit. hepat.funct.for sev.mnths.in pts.co-infect.with HIV & HBV   pervers., flush., tachycard., CNS sympts. incl.hallucinat., asthma, si-  tent.incr.dofetilide/pilsicainide plasma conc., decr.AUC & C max with
       who discont.ther.& appropr.init.of anti-hepatit. B ther.poss.necess.,   nusit., URTI, incr. sweat., acne, alopec., fatig., pain, alcoh. intol., hot   antacids cont. polyval. cations/prod.cont. Ca/ & Fe.
       consult profess.info. of meds.used in combinat.bef.init.ther., eval.for   flushes, malaise, influenza-like sympts., syncope, redistribut./accumi-
       signs of fat redistrib., monit.fast.ser.lipids & bld. gluc. lev., CV risk   lat.of body fat, hepat. fail., elev.ALT/AST lev., lumb.spine/hip & both   PREZISTA, Janssen [P/S]
       assessm.with evid.of lipodystrophy, immune reactivat.syndr., pts.to   arms BMD decr.from baseline, suicid.ideat./delus. & pyschos.-like   Darunavir
       seek med. advice if experienc.joint pain/aches/stiffn./ movem.diffic.  behav., rais.ser.cholestr.& triglycer. conc., immune reconstitut. syndr.  Indications: Treatm.in combinat.with 100 mg ritonavir and other
       as osteonecros.poss., opportunist. infects.& other HIV complicat.may   Special precautions: Ther.init.by physic.exper.in HIV infect.man-  antiretrovir.agents of HIV infect. in treatm.exper.adults who are
                                                                  protease-inhibit.-naïve/ aft.exclus. of darunavir resist.assoc.mutat.
       still devel., ARV ther.will not prev.transmiss.through sex.cont.& bld.   agem., monit.hepat.funct.for sev. mnths. in pts.co-infect.with HIV
       transfus.& appropr.precaut.to contin., discont. in pts.develop.clinic./  & HBV who discont. ther.& appropr.init.of anti-hepatit.B ther. poss.  (S4) TABS, 45/20.2.8/0616
       lab.findings suggest.lact. acidos./hepatotox., pts.with hepatomeg-  necess., obesity & prolong.nucleoside use poss.risk fact.for lact.aci-  719711-001: 600 mg, 60, R1 068,76
       aly/ hepatit/other risk facts.for liv.dis./hepat.steatos., pts. co-infect.  dos., liv.dis.risk fact., discont. if find.suggest.lact.acidos./hepatotoxic.,   Dosage: Always admin.with 100 mg ritonavir & in combinat.with
       with hepatit.C & treat.with alpha interferon & ribavarin, eff.on clinic.  test for chron.hepatit.B bef.init.ther., determ. creatin.clear.bef.init.  other anti-retrovir. Admin.with food.
       progress.of HIV-1 not demonstrat., investig.childr.expos.in utero to   ther., avoid with concom./ rec. nephrotox.agents, ren.funct.monit.in   Adults: Recomm.dos: 600 mg 2xdly with 100 mg ritonavir 2xdly.
       nucleoside & nucleotide analog.for poss. mitochondr.dysfunct.in   pts.at risk /hist.of ren.dysfunct., incr.ren.toxic.risk with adefovir dipiv-  (S4) TABS, 47/20.2.8/1173
       case of relev.S&S, discont. ther.until pancreatit.excl.in cases of   oxil, high.tenovofir conc.poss.potent. assoc.S/E incl.ren.disords., Ca   3000049-001: 400 mg, 60, R675,93
       N&V/abdom. pain/elev.biochem.mark., ren.funct.impairm., poss.   chann.blocks.dos. adjustm. advis., per. carbamazepine lev.monit.   Dosage: Always admin.with 100 mg ritonavir & in combinat.with
       incr.conc.of Nuvaco &/ other ren.elimin.meds with meds.reduc.ren.  with concom.use, altern.anticonvuls.agent advis., rash report.with   other anti-retrovir. Admin.with food.
       funct./compete for act.tubul. secret, monit.ren.funct.bef.init.ther &   efavirenz & clarithromycin theref. consid.alt., combinat.with other   Adults: Recomm.dos: 800 mg once dly with 100 mg ritonavir
       periodic. thereaft., avoid combin.with concurr./recent nephrotox./  macrolides not stud., poss.incr.didanosine-relat.adverse eff., somet.   once dly.
       concom.meds.secret.by same ren. pathway but monit.ren.funct.  fatal with concom.use, monit.cholest.lev. with atorvastatin/pravas-  (S4) TABS, 46/20.2.8/0850, 46/20.2.8/0851
       wkly.if use unavoidable, avoid in antiretrov.exper.pts.with HIV-1 har-  tatin/simvastatin, poss. tacrolimus dos.adjustm.& close conc.monit.   719709-001: 75 mg, 480, R1 068,76
       bour.K65R mutat., monit.liv.funct.in pts. with pre-exist.liv.dysfunct.,   esp. when init./stop.ther., no dos.recomm.for itraconazole avail.  719710-001: 150 mg, 240, R1 068,76
       consid.ther.interrupt./ discont.if evid.of worsen.liv.dis., incr.risk for   theref.seek.alt.antifung., high. freq.adverse events with efavirenz/  Indications: Treatm.in combinat.with low dos. ritonavir and
                                                                  other antiretrovir.agents of HIV infect.in treatm.exper.paed.pts of
       sev. hepat.adverse effs.in chron.hepatit.B or C co-infect., ref.to PI of   ritonavir, monit. liv.enzym.with efavirenz/ritonavir, monit. withdr.signs
       concom.hepat.B or C meds., bone monit.in pts. with patholog.bone   with methadone, barr.contracept.tog. with other methods recomm.,   6 yrs. to &lt; 18 yrs.
       fract.hist./ osteopen.risk, Ca & vit.D supplementat.poss. benefic.,   per.anticonvuls. plasma monit.if substr.of CYP450 isoenzym., do not   Dosage:  Always admin.with low-dose ritonavir & in combinat.with
       exacerbat.of hepatit.incl.treatm.flares & flates aft.treatm.discont.  admin.concom.saquinavir as sole protease inhibit., women of child-  other anti-retrovir.meds. Admin. with food.
       with resumpt.of hepatit.B ther.poss.necess., discont.not recomm.in   bear.potent.should undergo pregn.test.bef.init.ther., not known if efa-  ARV treatm.-exper.paed.pts (6 to &lt;18 yrs.):  ≥20 kg – &lt;30 kg:
       advanc. liv.dis./cirrhos., discont.ther.immed.if any hypersens. react.  virenz/emtricitabine/tenofovir excret.in breast milk, elderly, monit.for   375 mg with 50 mg ritonavir 2xdly. ≥30 kg – &lt;40 kg: 450 mg with
       susp./occurs.& init.appropr.ther., limit. data in elderly &gt; 65 yrs., avoid   hepatit.exacerbat.if treatm. discont.in HIV & HBV co-infect.pts., separ.  60 mg ritonavir 2xdly. ≥40 kg: 600 mg with 100 mg ritonavir 2xdly.
       if pregn. plann., reproduct.toxic.report., pregn.test in women of child-  preps. avail. if treatm.discont./dos.modific.of Odimune compon.indi-  Contraindications: Childr.&lt;3 yrs., no info.on use in antiretrovir.
       bear. potent.bef.init./periodic.dur. treatm. & when pregn.suspect.,   cat., consid.efavirenz long half-life & long emtricitabine & tenofovir   treatm.naïve pts., the presence of a contra-indicat.to ritonavir, con-
                                                                  com.meds.high. depend. on CYP3A4 for clear.& where incr.plasma
       lamivudine & tenofovir excret.in breast milk, monit.with concom. co-  intracell.half-liv.if treatm.discont., monit.BMD in pts.with patholog.
       trimoxazole, concom.ETR not recomm.unless receiv.concom. ATV +   bone fract. hist./at risk of osteopen., Ca & vit.D supplementat.poss   conc. are assoc.with ser./life threaten.events (ie. carbamazepine/
       RTV/ LPV + RTV or DRV + RTV, avoid concomit.cytidine analog. incl.   benefic., discont.ther.with sev.skin rash assoc.with blister./desqua-  phenobarbit./phenytoin/ astemizole/ alfuzocin/sildenafil (for pulm.
       emtricitabine, avoid concom.cladribine, avoid products cont.sorbi-  mat./ mucos. involvem.& fev., treatm.discont.poss.reqd. if ser.psych.  hypertens.)/ rifampicin/rifabutin/bosentan/ colchicine/ dihydroer-
       tol/xylitol/mannitol/lactitol & maltitol, admin.2 hrs.bef./ 6 hrs.aft.  sympt.exper., liv.enzym.monit.in pts. with known/susp.Hepatit.B or C   gotamine/ergonovine/ ergotamine/ methylergonovine/cisapride/
       polyval.cation-cont.antacids & Ca/Fe supplem.  or treat.with meds. assoc.with hepat.toxic., eval.risk vs.benef.of cont.  boceprevir/ telaprevir, St John’s Wort/lovastat./ simvastat./ pravas-
       Interactions: Conc.of isoniazid incr.by dolutegravir, lamivudine   ther.if ser.transaminase.lev.persist. 5x&gt;ULN, monit.triglycer./cholestr.  tat./ pimozide/ midazolam/ triazolam/ketoconazole/ itraconazole/
       poss.inhib.intracellul. phosphorylat. of zalcitabine, trimethoprim   lev., pt.on treatm.may devel. opportunist. infect./other HIV infect.  voriconazole/ buprenorphine/naloxone, sev.hepat. impairm., con-
       incr. lamivudine plasma lev., lamivudine incr.expos.& peak. plasma   compl., contin. appr.precaut.prevent.HIV transmiss.risk.  com.rifampicin, safety in pregn.not est., lactat., safety & effic.in
                                                                  ARV treatm.-exper. childr. 3 to &lt;6 yrs & in ARV treatm.naïve paed.
       lev. of zidovudine, conc.of tenofovir /concom.med incr.with concom.  Drug interactions: Efavirenz decr .voriconazole plasma conc.& vice
       drugs elimin.by glomerul. & act.tubul.secret., tenofov.ser.conc.incr.   versa, amprenavir ser.conc decr., conc.of drugs elimin.by act.tubul.  pts. not est., safety & effic.of once dly.dos.in paeds. not establish.
       by agents decr.ren.funct., Cmax & AUC of didanosine incr., atazanavir   secret.may incr., plasma conc.of other compds.that are CYP3A4   Side effects: Sev.skin rash incl.Stev.John., prurit., tox.epiderm.
       incr.tenofovir C max/ AUC/C min., lopinavir/ritonavir incr.tenofovir AUC/   substrat.poss.decr., atazanavir/ritonavir incr.tenofovir conc., poss.  necrolys., exanthemat. pustulos., angioed., urticar., hypersens.,
       C min., indinavir incr.tenofovir C max, saquinavir/ ritonavir incr.tenofovir   Ca chan.block.conc. decr., decr. carbamazepine lev., clarithromyc.   new onset diab. mellit., exacerbat.of pre-exist.diab.mellit., hyper-
       C min, tenofovir incr.C max of abacavir, tenofovir incr/decr.C max/AUC/  plasma lev.chang., didanosine conc.incr.with multip. tenofovir dos.,   glycaem., diabet.ketoacidos., anorex., dyslipidaem. ,incr. LDL,  GI
       C min of atazanavir, tenofovir decr.C max/AUC/C min of atazanavir + ri-  HMG-CoA reduct. inhibit./ indinavir/ itraconazole conc.decr., potent.  disturbs., headache, abdom.pain, fatig., asthen., incr.hepat.& pan-
       tonavir, tenofovir incr.C max/AUC/C min of saquinavir + ritonavir, poss.  decr. ketoconazole conc., decr.lopinavir expos.with lopinavir/ritona-  creat. enzym., hypertriglyceridaem., hypercholesterolaem., insul.
       reduc.effic.of cladribine, poss.decr.dolutegravir conc.with induc.   vir & efavirenz, decr.methadone plasma conc.& poss.opiate withdr.  resist., hyperlactataem., immune reconstit.syndr., abnorm. dreams,
       of UGT1A3/UGT1A3/ UGT1A9/ CYP3A4/Pgp/ BCRP, poss.incr.do-  signs with efavirenz, ethinyl oestrad.conc.incr., reduc./incr. plasma   ac.pancreatit.& hepatit., lipodystrophy, lipoatrophy, gynaecomast,
       lutegravir conc.with inhibits.of UGT1A3/ UGT1A9/ CYP3A4/Pgp,   lev.of phenytion/phenobarb./other anticonvuls which are substrat.  osteonecros., myalg.
       signif.reduc. dolutegravir plasma conc.with tipranavir/ efavirenz/   of CYP450 isoenzym., rifampicin decr.efavirenz conc., rifabutin conc.  Warnings and special precautions: Consult ritonavir prescrib.
       nevirapine/rifampicin, reduc. dolutegravir plasma conc.with etra-  decr., sequinavir conc.reduc., sertraline conc.decr., reduc.efavirenz   info for precaut.meas., discont.in pres. of sev.skin rash, known sul-
       virine/ fosamprenavir, poss.incr.metformin/dofetilide/ pilsicainide   conc.with St John’s Wort expect., poss.incr.conc.of emtricitabine /  phonam.allergy, pre-exist. liv.dysfunct., poss.persist.of hypergly-
       plasma conc.with dolutegravir., poss. decr. dolutegravir conc.with   tenofovir &/ other renal.elimin. meds with meds.reduc.ren.funct./  caem. despite discont., alt.non-hormon. contracept., admin.concom.
       oxcarbazepine/ phenytoin/ phenobarb./carbamazepine/St John’s   compete for act. tubul. secret.  didanosine 1 hr.bef./2 hrs.aft., concom.efavirenz/saquinavir or lopi-
       Wort though no studies, incr.dolutegravir plasma conc. with ataza-  navir/ ritonavir combinat, used with ritonavir only as a pharmacoki-
       navir, atazanavir + ritonavir, decr. dolutegravir conc.with tipranavir   OLEGRA, Aurobindo [P/S]  net. enhanc.theref.be familiar with ritonavir prescrib.info., monit.of
       + ritonavir/ fosamprenavir + ritonavir  Dolutegravir       concom. antidysrhythm. /immunosuppress./methadone & buprenor-
                                     Indications: HIV treatm.in adults 18 yrs.& old.in combinat.awith
                                                                  phine, caref.digox.titrat., monit.INR with concom.warfar., concom.
       ODIMUNE, Cipla Medpro [P/S]   other antiretrovir.ther.     PDE-5 inhibit./SSRI’s /colchicine/trazodone, concom. artemether/ lu-
       Emtricitabine 200 mg, tenofovir disoproxil fumarate 300 mg, efa-  (S4) TABS, 51/20.2.8/0914.913  mefantrine, myalg./myosit.& rhabdomyolys. report. with prot.inhibit.
       virenz 600 mg.                3000878 -001: 50 mg, 30, R791,03  use partic.in combinat.with NRTI’s, poss.inflamm.react.to asympto-
       Indications: HIV-1 infect.treatm.in adults.  Dosage: Admin.by med.pract.exper.in HIV treatm.  mat./ resid. opportunist.infects.if sev.immune defic.when init. ther.,
       (S4) TABS, 44/20.2.8/0779     Adults: Treatm.naive & treatm.-exper.and integrase inhibit.  monit.co-infect.hepat.B&C pts., consid. interrupt./discont.of treatm.
       716768-001: 30, R466,97       naive: Recomm.dos: 50 mg once dly.  with new/worsen.liv. dysfunct., opportunist.infects. & HIV complicat.</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page311.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page307.html">307</a>&nbsp;&nbsp;&nbsp;<a href="page308.html">308</a>&nbsp;&nbsp;&nbsp;<a href="page309.html">309</a>&nbsp;&nbsp;&nbsp;<a href="page310.html">310</a>&nbsp;&nbsp;&nbsp;<a href="page311.html">311</a>&nbsp;&nbsp;&nbsp;<a href="page312.html">312</a>&nbsp;&nbsp;&nbsp;<a href="page313.html">313</a>&nbsp;&nbsp;&nbsp;<a href="page314.html">314</a>&nbsp;&nbsp;&nbsp;<a href="page315.html">315</a>&nbsp;&nbsp;&nbsp;<a href="page316.html">316</a>&nbsp;&nbsp;&nbsp;<a href="page317.html">317</a>
             </td>
             <td width="35%"><a href="page313.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page313.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
